Trial
NCT04381429
Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University Hospital, Strasbourg, France
Collaborators
—
Condition
Cystic Fibrosis-related Diabetes
Intervention
A-F-A-F (NovoRapid-FIASP-NovoRapid-FIASP)
Why stopped
Difficulties of inclusion in this rare pathology
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-05